These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 33822440)

  • 21. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis.
    Wang B; Sun X; Huang KJ; Zhou LS; Qiu ZJ
    World J Gastroenterol; 2021 May; 27(17):1993-2014. PubMed ID: 34007135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.
    Liu Y; Li L; Wang JY; Gao F; Lin X; Lin SS; Qiu ZY; Liang ZH
    Mol Cell Biochem; 2023 Apr; 478(4):707-719. PubMed ID: 36036334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R/Akt signaling.
    Chen XX; Zhang N; Fu XF; Jiang Y; Wang MY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7698-7708. PubMed ID: 32744696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
    Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
    Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA nuclear receptor subfamily 2 group F member 1 antisense RNA 1 (NR2F1-AS1) aggravates nucleus pulposus cell apoptosis and extracellular matrix degradation.
    Du L; Li X; Gao Q; Yuan P; Sun Y; Chen Y; Huang B; Deng Y; Wang B
    Bioengineered; 2022 Feb; 13(2):2746-2762. PubMed ID: 35094651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis.
    Lin Q; Jia Y; Zhang D; Jin H
    Cancer Cell Int; 2021 Jul; 21(1):367. PubMed ID: 34247598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression.
    Zuo F; Zhang Y; Li J; Yang S; Chen X
    Bioengineered; 2021 Dec; 12(2):12345-12356. PubMed ID: 34738863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guizhi Fuling pills inhibit the proliferation, migration and invasion of human cutaneous malignant melanoma cells by regulating the molecular axis of LncRNA TPT1-AS1 / miR-671-5p.
    Zhang B
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):148-154. PubMed ID: 33040829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.
    Hu C; Li S; Fu X; Zhao X; Peng J
    Cytokine; 2023 Feb; 162():156105. PubMed ID: 36527891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.